总时间（秒）：9.24
问答时间（秒）：7.28

Based on the provided literature, I will extract and standardize the information according to the predefined JSON framework.

**Variants Include**

* Gene: LRRK2
* Variants:
	+ HGVS: NM_024415.5:c.5338G>A (standardized via API)
	+ cDNA Change:
		- Transcript: NM_024415.5
		- Ref: G
		- Alt: A
		- Position: 5338
	+ Protein Change:
		- Ref: G
		- Alt: R
		- Position: 1773
	+ Description in input context: c.5338G>A (p.R1773G)

**Described Disease**

* Described Disease: Parkinson's disease
* MONDO: MONDO:0005515

**Experiment Method**

* Assay Method: KESTREL screen
* Material used:
	+ Material Source: Rat brain extracts
	+ Material Name: N.D.
	+ Description: N.D.
* Readout type: Quantitative
* Readout description:
	+ Variant: NM_024415.5:c.5338G>A
	+ Conclusion: Abnormal
	+ Molecular Effect: partial loss-of-function
	+ Result Description: Phosphorylation of moesin at Thr558 was affected.
* Biological replicates:
	+ Biological replicates: N.D.
	+ Description: N.D.
* Technical replicates:
	+ Technical replicates: N.D.
	+ Description: N.D.
* Basic positive control:
	+ Basic positive control: N.D.
	+ Description: N.D.
* Basic negative control:
	+ Basic negative control: N.D.
	+ Description: N.D.
* Validation controls P/LP:
	+ Validation controls P/LP: N.D.
	+ Counts: N.D.
* Validation controls B/LB:
	+ Validation controls B/LB: N.D.
	+ Counts: N.D.
* Statistical analysis method:
	+ Statistical analysis method: N.D.
* Threshold for normal readout:
	+ Threshold for normal readout: N.D.
	+ Source: N.D.
* Threshold for abnormal readout:
	+ Threshold for abnormal readout: N.D.
	+ Source: N.D.
* Approved assay:
	+ Approved assay: No

Note: Since the literature does not provide detailed information about some of the experimental methods, I have marked those fields as "N.D." (Not Determined). Additionally, the HGVS nomenclature was standardized via API to obtain the correct format.